Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Educate, explore options to limit risks for statin-intolerant patients Regina Schaffer; Michael Monostra
-
- Adults with obesity using tirzepatide maintain ‘remarkable’ weight loss at 88 weeks Michael Monostra
- AHA highlights disease overlap with new term: Cardiovascular-kidney-metabolic syndrome Regina Schaffer
- Early glycemic control may not prevent beta-cell deterioration in youth-onset diabetes Michael Monostra
- FDA committee unanimously rejects GLP-1 implant for type 2 diabetes
- From menarche to menopause, reproductive history may reveal heart disease risk Regina Schaffer
- HbA1c cutoff for diagnosing diabetes likely too high for premenopausal women Michael Monostra
- Hybrid closed-loop therapy increases time in range for pregnant women with type 1 diabetes Michael Monostra
- Lack of knowledge, distress are barriers to active surveillance for thyroid cancer Michael Monostra
-
- More exposure to natural daylight may improve metabolic metrics in type 2 diabetes Michael Monostra
- Not ‘panacea nor poison’: No long-term cognitive effects of menopausal hormone therapy Jill Rollet
- Novo Nordisk sees positive results in impact of semaglutide on kidney function, ends trial Mark E. Neumann
- Teprotumumab, tocilizumab improve thyroid eye disease symptoms within 24 weeks Michael Monostra
- Testosterone therapy may lower HbA1c for men with type 2 diabetes, hypogonadism Michael Monostra
- Top-dose phentermine/topiramate cost-effective after 5 years for adolescents with obesity Michael Monostra
- VIDEO: CVD risk stratification can be valuable when considering menopausal HT Jill Rollet; Cynthia A. Stuenkel, MD
- VIDEO: Tips for using automated insulin delivery during pregnancy Erin T. Welsh, MA; Carol J. Levy, MD, CDCES; Denice Feig, MD, MSc, FRCPC; Sarit Polsky, MD, MPH
-